AMS May Be Seeing A Turnaround

By Douglas A. McIntyre Published Nov 28, 4:28AM EST

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

From BioHealth Investor

by Alligator Investor

American Shares Hospital Services (AMS) is a tiny company with a market cap of only 31M. The stock is thinly traded and jumps around quite a bit for a security with a low beta of .46. It is too
small for me, but someone may be interested.

AMS has performed poorly in relation to the S&P 500, but a turnaround may be in progress, judging by the last three months price action. Recent earnings have been good and the stock looks cheap. There is a 3.07% dividend yield and the company has definite growth potential. In addition, there has been insider buying activity in the last three months.

AMS and its subsidiaries provide Gamma Knife stereotactic radiosurgery services to medical centers in the United States. The Gamma Knife is a noninvasive treatment for brain tumors, vascular malformations, and trigeminal neuralgia. The company provides the Gamma Knife equipment, as well as planning, installation, reimbursement, and marketing support services to 21 medical centers in 18 states.

AMS also offers “The Operating Room for the 21st Century”, state-of-the-art surgical suites, at major medical centers on a fee-for-use or other shared basis. These operating rooms incorporate diagnostic imaging equipment to guide surgical procedures, with computer-controlled navigation systems an integral component. Robotic technology is included to provide assistance to the surgeon. The suite includes a computer-controlled, motorized combination operating room table and ICU bed with on-board sensors and dispensers for oxygen, anesthetic gases and intravenous fluids.

http://www.biohealthinvestor.com/

About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.